Arrowhead Research | ARWR - PE Price to Earnings


Arrowhead Research reported 41.67 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Anika Therapeutics 47.54 27.2 Jun/2024
Heron Therapeutics 6.46 3.23 Dec/2006
Incyte 14.84 2.79 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Ligand Pharmaceuticals 60.65 17.62 Sep/2025
Merck 13.92 5.08 Dec/2025
Moderna 27.22 14.51 Jun/2023
Novartis 17.85 2.11 Dec/2025
Sarepta Therapeutics 27.27 0 Sep/2025
TG Therapeutics 10.76 2.32 Dec/2025
Vertex Pharmaceuticals 26.15 2.22 Dec/2025
Xencor 29.92 3.22 Sep/2022